QRXPHARMA LTD. •
M A R K E T S E R V I C E S
QRXPHARMA LIMITED RESULT OF GENERAL MEETING (ASX REPORT)ANNUAL GENERAL MEETING
Thursday, 19 May, 2016
As required by section 251AA(2) of the Corporations Act 2001 (Commonwealth) the following statistics are provided in respect of each resolution on the agenda.
Manner in which the securityholder directed the proxy vote (as at proxy close): | Manner in which votes were cast in person or by proxy on a poll (where applicable) | ||||||
Resolution | Votes For | Votes Against | Votes Discretionary | Votes Abstain | For | Against | - - Abstain ** |
1 ADOPTION OF THE REMUNERATION REPORT | 35,234,390 | 8,581,483 | 1,369,631 | 140,378 | 39,835,170 82.21% | 8,621,483 17.79% | 140,378 |
2 RE-ELECTION OF DR RICHARD TREAGUS AS A DIRECTOR | 41,669,743 | 3,792,290 | 119,131 | 51,003 | Passed on a show of hands | Passed on a show of hands | Passed on a show of hands |
** - Note that votes relating to a person who abstains on an item are not counted in determining whether or not the required majority of votes were cast for or against that item
Printed: 19/05/2016 1O: 17:58AM This report was produced from the Link Market Services System Page 1 of1
QRxpharma Ltd. published this content on 19 May 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 19 May 2016 03:07:06 UTC.
Original documenthttp://www.qrxpharma.com/irm/PDF/1513/Resultsof2015AnnualGeneralMeeting
Public permalinkhttp://www.publicnow.com/view/8BD23C66643633B5DCCC679C32B43F2E9F6E2038
